Pay in 4 interest-free payments of $19.50 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Specific control of pancreatic endocrine β- and δ-cell mass by class IIa histone deacetylases HDAC4
resulting in accumulation of ubiquitinated substrates
Smiles: CC(=O)NC1C=CC(=CC=1)C(=O)NC1=CC=CC=C1N
Smiles: O=C(COC1C(Cl)=CC(Cl)=CC=1Cl)N/N=C/C1=CC=CN1
AGI-6780 - Mutant IDH2 Inhibitor. CAS# 1432660-47-3 60218 Specific control of pancreatic endocrineAGI 6780, CAS No. 1432660 47 3, is a potent and selective IDH2 inhibitor. AGI 6780 inhibits the tumor associated mutant IDH2 R140Q. Treatment with AGI 6780 induced differentiation of TF 1 erythroleukemia and primary human acute myelogenous leukemia cells in vitro. Inhibitors targeting mutant IDH2 R140Q could have potential applications as a differentiation therapy for cancer. Product information CAS Number: 1432660 47 3 Molecular Weight: 481. 51
US$ 293.50
US$ 30.00
US$ 1081.50
US$ 471.50
US$ 197.50